Abhishek Kumar: Next-Gen Insights on Antiphospholipid Syndrome Care
Abhishek Kumar, Lead Analyst at DelveInsight Business Research LLP, shared a post on LinkedIn:
“Next-Gen Antiphospholipid Syndrome Pipeline Insights Transforming Autoimmune Care
Antiphospholipid Syndrome is gaining attention as research shifts from symptom control to precision immunology. Scientists are exploring complement inhibition, B-cell modulation, and targeted biologics to reduce clot risk, inflammation, and pregnancy complications. Growing awareness, improved diagnostics, and expanding clinical trials are accelerating therapeutic innovation. The future of APS care may soon include disease-modifying treatments that address immune mechanisms rather than only preventing thrombosis. Discover how emerging science is reshaping autoimmune management and guiding next-generation treatment strategies for better long-term outcomes and patient quality of life.
Recent developments include, National Institute of Allergy and Infectious Diseases (NIAID) announced result of Targeting CD38 With Daratumumab in Primary Antiphospholipid Syndrome: A Phase 1b Dose Escalation Safety Trial (ITN093AI).
The Antiphospholipid Syndrome Companies include Genentech (Roche), Sanofi, Bristol Myers Squibb, Teva Pharmaceuticals, Pfizer, Novartis, and others.
Learn more about rare disease innovation and next-generation therapies today.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 16, 2026, 01:10Christopher Robinson: Immune Tolerance Breakdown in Pregnancy
-
Apr 16, 2026, 01:06Standardizing Ultrasound Assessment of Adnexal Tumors – ISUOG
-
Apr 15, 2026, 16:38Why an Ovulation Trigger Shot Sometimes Fails – Fertility Plus
-
Apr 15, 2026, 16:3374 New Studies Added to the AC Forum Literature Library – Anticoagulation Forum
-
Apr 15, 2026, 16:23Insights from PGT-A in Recurrent IVF Failure – Motherhood Training Center
-
Apr 15, 2026, 16:20Effect of Endometriosis and Adenomyosis on Oocyte Quality and Morphology – RBMO
-
Apr 15, 2026, 11:37Ally Murji: Honoured to be Part of the Canadian Session at the SEUD Meeting
-
Apr 15, 2026, 11:00Scammers are Targeting ESHRE2026 Attendees With Fake Registration and Hotel Offers – ESHRE
-
Apr 15, 2026, 10:24Join Us This Friday for Our “Research in Progress” – SRF